6340-81-4 Usage
Uses
Used in Research and Clinical Settings:
DCFDA is used as a fluorescent probe for measuring cellular redox status and oxidative stress, which is important in the study of cell physiology and pathology.
Used in Flow Cytometry and Microscopy Applications:
DCFDA is used as a fluorescent marker in flow cytometry and microscopy applications, allowing for the visualization and analysis of cellular processes.
Used in Drug Delivery and Therapeutic Applications:
DCFDA is being investigated for its potential in drug delivery and therapeutic applications due to its unique chemical structure and reactivity, which may offer new ways to treat various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 6340-81-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,4 and 0 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6340-81:
(6*6)+(5*3)+(4*4)+(3*0)+(2*8)+(1*1)=84
84 % 10 = 4
So 6340-81-4 is a valid CAS Registry Number.
InChI:InChI=1/C22H18O3/c23-20(16-17-10-4-1-5-11-17)25-22(19-14-8-3-9-15-19)21(24)18-12-6-2-7-13-18/h1-15,22H,16H2
6340-81-4Relevant academic research and scientific papers
Ceric ammonium nitrate promoted oxidation of oxazoles
Evans, David A.,Nagorny, Pavel,Xu, Risheng
, p. 5669 - 5671 (2007/10/03)
The ceric ammonium nitrate promoted oxidations of 4,5-diphenyloxazoles and oxazoles with various substitution patterns have been investigated. This transformation results in the formation of the corresponding imide in good yield and tolerates a wide variety of functional groups and substituents on the oxazole moiety.
Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5- diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted α to the oxazole ring
Meanwell,Rosenfeld,Wright,Brassard,Buchanan,Federici,Fleming,Gamberdella,Hartl,Zavoico,Seiler
, p. 3871 - 3883 (2007/10/02)
The 4,5-diphenyloxazole derivatives 2-4 were previously identified as nonprostanoid prostacyclin (PGI2) mimetics. A series of derivatives of 2-4 bearing substitutents at the carbon atom α to the oxazole ring were synthesized and evaluated as in
